Yelena Y Janjigian Selected Research

Indicators and Reagents (Reagents)

12/2022

Survival After Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yelena Y Janjigian Research Topics

Disease

76	Neoplasms (Cancer) 03/2024 - 04/2010
40	Adenocarcinoma 02/2024 - 04/2014
28	Stomach Neoplasms (Stomach Cancer) 03/2024 - 05/2011
7	Esophageal Neoplasms (Esophageal Cancer) 02/2024 - 01/2020
6	Disease Progression 12/2023 - 12/2012
6	Neoplasm Metastasis (Metastasis) 01/2023 - 12/2010
5	Microsatellite Instability 01/2023 - 01/2018
4	Esophageal Squamous Cell Carcinoma 02/2024 - 12/2015
4	Lung Neoplasms (Lung Cancer) 09/2014 - 10/2011
3	Carcinoma (Carcinomatosis) 02/2024 - 01/2017
3	Pathologic Complete Response 06/2023 - 01/2016
3	Fatigue 11/2017 - 04/2010
3	Breast Neoplasms (Breast Cancer) 10/2016 - 11/2011
3	Adenocarcinoma of Lung 12/2012 - 03/2011
2	Nausea 12/2023 - 12/2023
2	Leukemia 01/2023 - 01/2023
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 11/2022
2	Carcinogenesis 11/2022 - 12/2018
2	Colorectal Neoplasms (Colorectal Cancer) 12/2019 - 02/2016
2	Exanthema (Rash) 11/2017 - 04/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2017 - 12/2010
2	Colonic Neoplasms (Colon Cancer) 02/2016 - 04/2014
1	Pneumonia (Pneumonitis) 12/2023
1	Colitis 12/2023
1	Sepsis (Septicemia) 12/2023
1	Acute Kidney Injury (Acute Renal Failure) 12/2023
1	Residual Neoplasm 11/2023
1	Margins of Excision 11/2023
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2023
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023
1	Atherosclerosis 01/2023
1	Obesity 11/2021

Drug/Important Bio-Agent (IBA)

16	Trastuzumab (Herceptin)FDA Link 12/2023 - 11/2013
15	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2011
13	Immune Checkpoint InhibitorsIBA 02/2024 - 07/2018
12	human ERBB2 proteinIBA 12/2023 - 11/2011
11	NivolumabIBA 02/2024 - 10/2018
10	pembrolizumabIBA 12/2023 - 07/2018
9	ErbB Receptors (EGF Receptor)IBA 01/2022 - 03/2011
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2011
6	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 04/2014
6	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2017 - 03/2011
6	Gefitinib (Iressa)FDA Link 11/2017 - 03/2011
6	Tyrosine Kinase InhibitorsIBA 01/2015 - 03/2011
5	AfatinibIBA 01/2019 - 10/2012
4	zirconium-89-trastuzumabIBA 01/2023 - 06/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2019
4	Cetuximab (Erbitux)FDA Link 11/2017 - 04/2011
3	B7-H1 AntigenIBA 03/2024 - 10/2018
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2024 - 06/2013
3	PlatinumIBA 12/2023 - 01/2011
3	Phosphotransferases (Kinase)IBA 01/2022 - 09/2014
3	IpilimumabIBA 01/2022 - 10/2018
3	RamucirumabIBA 01/2022 - 01/2016
3	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 11/2015
3	EnzymesIBA 12/2019 - 02/2016
3	Bevacizumab (Avastin)FDA Link 12/2016 - 12/2010
2	regorafenibIBA 10/2023 - 01/2020
2	durvalumabIBA 01/2023 - 06/2022
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2022 - 01/2011
2	NucleotidesIBA 01/2022 - 12/2019
2	Caveolin 1IBA 01/2022 - 12/2018
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 01/2018
2	Lovastatin (Mevacor)FDA LinkGeneric 11/2019 - 12/2018
2	Docetaxel (Taxotere)FDA Link 01/2019 - 11/2015
2	Formaldehyde (Formol)FDA Link 01/2017 - 11/2011
2	Epirubicin (Ellence)FDA LinkGeneric 01/2017 - 08/2016
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2017 - 05/2011
2	ParaffinIBA 01/2017 - 11/2011
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2016 - 04/2014
2	Epidermal Growth Factor (EGF)IBA 10/2016 - 04/2014
2	Lapatinib (GW572016)FDA Link 02/2016 - 11/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2015 - 04/2014
2	RNA (Ribonucleic Acid)IBA 05/2011 - 05/2011
1	AlbuminsIBA 03/2024
1	Trinitrotoluene (TNT)IBA 06/2023
1	Small Cytoplasmic RNAIBA 01/2023
1	Circulating Tumor DNAIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 12/2022
1	CarcinogensIBA 10/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	crenolanibIBA 01/2022
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	CholesterolIBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022

Therapy/Procedure

47	Therapeutics 12/2023 - 03/2011
38	Drug Therapy (Chemotherapy) 02/2024 - 12/2010
11	Neoadjuvant Therapy 02/2024 - 01/2018
9	Immunotherapy 02/2024 - 01/2016
6	Esophagectomy 11/2023 - 01/2018
6	Gastrectomy 11/2021 - 04/2015
5	Chemoradiotherapy 02/2024 - 01/2018
5	Induction Chemotherapy 01/2023 - 12/2015
3	Adjuvant Chemotherapy 12/2023 - 01/2019
2	Radiotherapy 01/2023 - 12/2010
1	Combination Drug Therapy (Combination Chemotherapy) 04/2023
1	Lymph Node Excision (Lymph Node Dissection) 01/2022
1	Minimally Invasive Surgical Procedures 07/2021
1	Combined Modality Therapy 01/2021